3,725
+1.64%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Kissei Pharmaceutical Co
Its shares trade on Tokyo Stock Exchange under the ticker 4547.T. It has been listed since 22 December 1988. In the fiscal year to 31 March 2026, it reported revenue of ¥97.41bn and net income of ¥13.78bn. At that date it held total assets of ¥275.09bn and shareholders' equity of ¥230.15bn.
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. The company is headquartered in Matsumoto-Shi, Nagano-Ken. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The firm is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. The company is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 22 Dec 1988
- Employees
- 1,907
- Website
- kissei.co.jp ↗
Leadership
Pay as last reported
- Mr. Mutsuo KanzawaChairman of the Board, Chief Executive Officer, Representative Director, since 1982
- Mr. Yasuo TakehanaPresident, Chief Operating Officer, Representative Director, since 2012
- Mr. Takahide KitaharaChief Financial Officer, Managing Director, Director of Finance and Administration, since 2018
- Mr. Keiji FukushimaVice President, Director, since 2012
- Mr. Tetsu TakayamaSenior Managing Director, since 2014
- Mr. Katsuji HozumiSenior Executive Officer, Manager of Kansai Office in Main Pharmaceutical Sales Unit
- Ms. Kaoru KanekoSenior Executive Officer, Chief Director of Reliability Assurance
- Mr. Yuji SeinoSenior Executive Officer, Chief Director of Development
- Mr. Hiroshi NoakeChief Director of Pharmaceutical Sales, Director, since 2022
- Mr. Yasuhiko KirisawaExecutive Officer, Director of Legal Affairs
- Mr. Takayuki KomamuraExecutive Officer, Director of Business Planning
- Mr. Yasumasa MishimaExecutive Officer, Director of Healthcare Business
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Kissei Pharmaceutical Co Ltd holds a strong market position in the pharmaceutical industry, backed by decades of experience and a well-established reputation.
- The company enjoys a diversified product portfolio, offering a range of innovative and high-quality pharmaceuticals in various therapeutic areas.
- Kissei Pharmaceutical has a robust research and development (R&D) department, consistently investing in cutting-edge technology and scientific advancements.
- The company's strong distribution network enables efficient product delivery to a wide customer base, both domestically and internationally.
Weaknesses
- Kissei Pharmaceutical faces intense competition from both domestic and international pharmaceutical companies, which may hinder its market share growth.
- The company heavily relies on a few key products for a significant portion of its revenue, making it vulnerable to potential product-related risks or market fluctuations.
- Kissei Pharmaceutical's international presence is relatively limited compared to some global competitors, potentially impacting its ability to capitalize on emerging markets.
Opportunities
- The growing global demand for pharmaceutical products presents an opportunity for Kissei Pharmaceutical to expand its market presence and increase revenue.
- Investing in research and development of new drug candidates could lead to the introduction of breakthrough therapies, driving market differentiation and growth.
- Collaborations and partnerships with other pharmaceutical companies or research institutions can enhance Kissei Pharmaceutical's access to new technologies and expertise.
Threats
- Government regulations and policies related to the pharmaceutical industry, including pricing controls and intellectual property rights, can pose challenges for Kissei Pharmaceutical.
- The ongoing COVID-19 pandemic and its potential long-term impacts on healthcare systems and drug development can affect the company's operations and financial performance.
- Fluctuating currency exchange rates and economic uncertainties in key markets may adversely affect Kissei Pharmaceutical's international business and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.